ADD ANYTHING HERE OR JUST REMOVE IT…
Wrong menu selected
Acarix Acarix
  • Product

    Background

    • What is Coronary Artery Disease (CAD)?
    • Diagnosing CAD

    About the product

    • The CADScor® System
    • How does it work
  • Resources

    Testimonials

    • HCP stories
    • Patient stories

    References

    • Clinical Studies
    • Questionnaire
    • Downloads (US)
    • Downloads (EU)
    • Education

    Support

    • Training
    • FAQ
    • Reimbursement

    Physician Locator

    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Rights Issue/Warrant Program
    • Previous Rights Issue
    • Investor Presentations
  • Company

    Who we are

    • About Acarix
    • leadership
    • Join the team

    Get in touch

    • Contact us
    • Investigator Initiated Study
  • News
    • Press
    • Events
    • Social Media
Account
Search
Book a Demo
Acarix Acarix
Book a demo
Menu
author-avatar acarix
Press
August 6, 2024
14 Sep 2021

Acarix inleder USA expansion och utser USA-chef

        PressmeddelandeMalmö, 14 september 2021 Acarix inleder USA expansion och utser USA-chef Acarix meddelar idag att företaget ha...
Continue reading
author-avatar acarix
Press
August 6, 2024
14 Sep 2021

Acarix begins US expansion and appoints US President

        Press releaseMalmö, Sweden, September 14, 2021 Acarix begins US expansion and appoints US President Acarix is announcing toda...
Continue reading
author-avatar acarix
Press
August 6, 2024
07 Sep 2021

New health economic study proves the value of CADScor® in coronary disease diagnostics

        Press releaseMalmö, Sweden, September 7, 2021 New health economic study proves the value of CADScor® in coronary disease diagn...
Continue reading
author-avatar acarix
Press
August 6, 2024
07 Sep 2021

Ny sjukvårdsekonomisk studie lägger fram bevis för värdet av CADScor® vid diagnostik av kranskärlssjukdom

        PressmeddelandeMalmö, 7 september 2021 Ny sjukvårdsekonomisk studie lägger fram bevis för värdet av CADScor® vid diagnostik av...
Continue reading
author-avatar acarix
Press
August 6, 2024
27 Aug 2021

Initial Dan-NICAD II results presented today at ESC

         Press releaseMalmö, Sweden, August 27, 2021 Initial Dan-NICAD II results presented today at ESC Study confirms excellent...
Continue reading
author-avatar acarix
Press
August 6, 2024
27 Aug 2021

Första resultaten från Dan-NICAD II presenteras idag på ESC

         PressmeddelandeMalmö den 27 augusti 2021 Första resultaten från Dan-NICAD II presenteras idag på ESC Studien bekräftar ...
Continue reading
author-avatar acarix
Press
August 6, 2024
23 Aug 2021

Preliminary Dan-NICAD II results to be presented at ESC

Press release Malmö, Sweden, August 23, 2021 Preliminary Dan-NICAD II results to be presented at ESC Acarix AB (publ) today annou...
Continue reading
author-avatar acarix
Press
August 6, 2024
23 Aug 2021

Preliminärt Dan-NICAD II-resultat presenteras på ESC

Press release Malmö, 23 augusti, 2021 Preliminärt Dan-NICAD II-resultat presenteras på ESC Acarix AB (publ) meddelar i dag att d...
Continue reading
author-avatar acarix
Press
August 6, 2024
19 Aug 2021

Acarix AB (publ) publishes Interim Report, January – June 2021

Press release Malmö, August 19, 2021 Acarix AB (publ) publishes Interim Report, January – June 2021 Continued positive trend with f...
Continue reading
author-avatar acarix
Press
August 6, 2024
19 Aug 2021

Acarix AB (publ) publicerar delårsrapport, januari – juni 2021

Press release Malmö, 19 augusti, 2021 Acarix AB (publ) publicerar delårsrapport, januari – juni 2021 Fortsatt positiv trend med foku...
Continue reading
author-avatar acarix
Press
August 6, 2024
11 May 2021

Acarix AB (publ) publicerar delårsrapport, januari – mars 2021

Press release Malmö, 11 maj, 2021 Acarix AB (publ) publicerar delårsrapport, januari - mars 2021 Förberedda att möta ett spännand...
Continue reading
author-avatar acarix
Press
August 6, 2024
11 May 2021

Acarix AB (publ) publishes Interim Report, January – March 2021

Press release Malmö, May 11, 2021 Acarix AB (publ) publishes Interim Report, January – March 2021 Prepared for an exciting 2021 ...
Continue reading
  • «
  • ‹
  • 20
  • 21
  • 22
  • 23
  • 24
  • ›
  • »
Acarix AB
Jungmansgatan 12
211 19 Malmö
SE
[email protected]

Product

Background

  • What is Coronary Artery Disease (CAD)?
  • Diagnosing CAD

About the product

  • The CADScor® System
  • How does it work

Resources

Testimonials

  • HCP stories
  • Patient stories

Support

  • Training
  • FAQ

References

  • Clinical Studies
  • Downloads (US)
  • Downloads (EU)

Investors

  • Corporate Governance
  • General Meetings
  • Financial Reports and Calendar
  • The Acarix Share
  • Rights Issue
  • Investor Presentations

Company

Who we are

  • About Acarix
  • Management
  • Join the team

Get in touch

  • Contact us
  • LinkedIn
  • Twitter

News

  • Press
  • Events
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy

Acarix, 2025. All rights reserved V5

  • Products
    • Background
    • What is Coronary Artery Disease
    • Diagnosing CAD
    • About the product
    • The Cadscor System
    • How Does it Work
  • Resources
    • Testimonial
    • HCP Stories
    • Patients Stories
    • References
    • Clinical Studies
    • Downloads (US)
    • Downloads (EU)
    • Support
    • Training
    • Faq
    • Reimbursement
    • Physician Locator
    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Right Issue
    • Previous Rights Issue
    • Investor Presentations
  • Company
    • Who we are
    • About Acarix
    • Leadership
    • Join The Team
    • Get in touch
    • Contact Us
    • Investigator Initiated Study
  • News
    • News
    • Press
    • Events
    • Socialmedia
Start typing to see products you are looking for.